No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Follow-Up Studies
-
Humans
-
Imatinib Mesylate
-
Lichenoid Eruptions / chemically induced*
-
Lichenoid Eruptions / physiopathology
-
Male
-
Middle Aged
-
Myeloproliferative Disorders / diagnosis
-
Myeloproliferative Disorders / drug therapy*
-
Piperazines / adverse effects*
-
Piperazines / therapeutic use
-
Pyrimidines / adverse effects*
-
Pyrimidines / therapeutic use
-
Risk Assessment
-
Severity of Illness Index
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate